Peer-reviewed Publications

Clinical Posters

A Prospective, Multicenter, Randomized, Masked, Controlled Pivotal Trial to Assess the Safety and Effectiveness of an Eye-Tracking-Based Treatment for Amblyopia Under Binocular Conditions vs. Patching- Interim Results.

Oren Yehezkel PhD, Avital Moshkovitz, Michael Belkin M.D, Tamara Wygnanski-Jaffe M.D.

ARVO 2022

Reading Performance Improvement in Amblyopic Children Using Binocular Eye Tracking Training and an Eye-tracking Based 30 Second Reading Test

Tamara Wygnanski-Jaffe, M.D; Michael Belkin, M.D; Oren Yehezkel Ph.D

AAPOS 2022 – Best of show

Objective Convergence Insufficiency and Fusional Convergence Amplitude Measurement with an Eye Tracking Based Device

Tamara Wygnanski-Jaffe, M.D; Michael Belkin, M.D; Oren Yehezkel Ph.D

ESA 2019

Objective Convergence Insufficiency and Fusional Convergence Amplitude Measurement with an Eye Tracking Based Device

Tamara Wygnanski-Jaffe, M.D; Michael Belkin, M.D; Oren Yehezkel Ph.D

AAOPS 2019

An eye-tracking-based dichoptic amblyopia home treatment is non-inferior to standard occlusion for amblyopia: 28 weeks follow-up

Tamara Wygnanski-Jaffe, M.D; Michael Belkin, M.D; Oren Yehezkel Ph.D

WSPOS 2023

Previous slide

Next slide

Branding & Website by

Branding & Website by

© 2022 NovaSight | All Rights Reserved | NS-00779-R08
CureSight™ and EyeSwift®^PRO devices are CE marked in accordance with EU Medical Device Regulation 2017/745.

CureSight™ is an FDA 510(K) cleared device.

Caution: The EyeSwift®^PRO system is an Investigational Device, Limited By Federal (Or United States) Law To Investigational Use.
Currently, TrackSight^TM is not approved for sales in any country.

Contact Us Today!

So children worldwide can pursue their dreams

First name*

Last name*

Email*

Country*

Select Country*

State*

I am*

Interested in*

Interested In*

Message

(*Required field)

Your data will be handled in accordance with our Privacy Policy. In the event that a child’s or minor’s information is being submitted as part of this form, we hereby request that such information be submitted solely by the legal guardian of such child or minor.